1
Registered trials
0
Recruiting
1
Unique sponsors
1
Unique IMPs
1
Commercial trials
Drug classes (ATC)
N
Neurology/Psychiatry (ATC N)
1
Mechanism of action (INN-stem analysis)
Monoclonal antibody (neural, humanized)
1 substance
Phase IV:
1
Phase IV
1 trial-
EndedH. Lundbeck A/S CommercialEPTINEZUMAB
Sponsor activity
| Sponsor | Type | Trials | Phases | Recruiting |
|---|---|---|---|---|
| H. Lundbeck A/S | Commercial | 1 | Phase IV | 0 |
New trials by year
2022
1